The Schwab U.S. Dividend Equity ETF yields around 4% today, which means that it would take an investment of approximately $50 ...

Pfizer has earned a consensus rating of “Moderate Buy” from fifteen analysts, with only one calling it a “sell.” The average ...

The dividend record date is when a company finalises eligible shareholders for dividend, e.g., if a company sets June 27, ...

Pfizer (NYSE:PFE) recently announced positive topline results from its Phase 3 BASIS study for HYMPAVZI™ and declared a third-quarter 2025 dividend of $0.43 per share. Alongside these developments, ...

Pfizer will pay a $0.43 quarterly dividend on September 2, 2025, maintaining its 347-quarter streak of shareholder payouts.

Pfizer's revenue slump is temporary. New launches and Seagen integration drive 2025 growth. Read here for an investment ...

With continued uncertainty over Washington's policy priorities plus a recent flare-up of geopolitical tensions in the Middle East, it seems like Wall Street may continue to focus on ...

There is perhaps no better way to put a $500,000 windfall to work than to stash it in a self-directed investment portfolio.

Pfizer Inc. (NYSE:PFE) is one of the Best Dividend Leaders to Buy Now. The company’s strategy focuses on steadily increasing ...

Manulife Philippines has partnered with Pfizer to promote disease awareness and patient education, as part of its Better Days ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...

Pfizer (NYSE:PFE) stock is a biopharmaceutical firm that had a magnificent breakout in 2021 as the worst of the pandemic sent ...